1Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies [ J ]. Am J Physiol Renal Physiol, 2007,292 (3) :905 -911.
2Somerville RP, Oblander SA, Apte SS. Matrix metaUoproteinases : old dogs with new tricks[J]. Genome Biol,2003,4(6) :216.
3Verstappen J, Von flen Hoff JW. Tissue inhibitors of metalloprotein- asses (TIMPs):their biological functions and involvement in oral disease [ J ]. J Dent Res,2006,85 (12) : 1074 - 1084.
4Lohi J, Wilson CL, Roby JD, et al. Epilysin, a novel human matrix metaUoproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury[J]. J Biol Chem,2001,276(13) :10134 - 10144.
5Maskos K, Bode W. Structural basis of matrix metaUoproteinases and tissue inhibitors of metal 1 oproteinases [ J]. Mol Biotechnol,2003,25 (3) :241 -266.
6Breyholz H J, Wagner S, Levkau B, et al. A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metallo- proteinase activity in vivo[ J]. Q J Nucl Med Mol Imaging,2007,51 (1) :24 -32.
7Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs [ M ]. New York:Oxford University Press,2002:91 -96.
8Alper O, Bergmann-Leitner ES, Bennett TA, et al. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma ceUs [ J ]. J Nail Cancer Inst,2001,93 ( 18 ) : 1375 - 1384.
9Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regula- tion:what is all the fuss about? [ J]. Matrix Biol, 1997,15 ( 8-9 ) : 519 -526.
10Kim HS, Kim HJ, Park KG, et al. Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcrip- tional activity[ J]. Exp Mol Med ,2007,39( 1 ) :106 -113.
